Combining the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, ZD1839, with a selective cyclooxygenase (COX)-2 inhibitor, SC236, causes a cooperative antitumor effect in breast cancer cells derived from HER2/neu mice

Author: Rosato F.E.   Dicker A.   Burd R.   Miller S.   Lanza-Jacoby S.  

Publisher: Elsevier

ISSN: 0022-4804

Source: Journal of Surgical Research, Vol.114, Iss.2, 2003-10, pp. : 274-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content